Extended field radiation therapy versus delayed hormonal therapy in node positive prostatic adenocarcinoma.
作者信息
Paulson D F, Cline W A, Koefoot R B, Hinshaw W, Stephani S
出版信息
J Urol. 1982 May;127(5):935-7. doi: 10.1016/s0022-5347(17)54136-1.
PMID:6806486
Abstract
This study was undertaken to determine the disease control and survival advantage of either extended field megavoltage irradiation or delayed androgen ablation in a randomized clinical trial. Comparison of the 2 treatments, using either time-to-first evidence of treatment failure or survival, demonstrates an advantage to extended field radiation.
摘要
Zotero 插件